Free tool
FAERS Monitor: Zosyn In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050750 or its brand name (Zosyn In Plastic Container, Piperacillin Sodium, Tazobactam Sodium). Reports on generic versions are filed under their own applications.
Reports
6,982
Serious
6,253
90% of reports
Hospitalization
3,828
Death reported
1,733
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- pyrexia565
- pneumonia553
- sepsis481
- acute kidney injury366
- diarrhoea362
- renal failure342
- dyspnoea332
- hypotension319
- nausea298
- anaemia280
- rash276
- thrombocytopenia267
- respiratory failure265
- febrile neutropenia263
- pain251
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 214 |
| 2005 | 207 |
| 2006 | 244 |
| 2007 | 165 |
| 2008 | 225 |
| 2009 | 322 |
| 2010 | 357 |
| 2011 | 412 |
| 2012 | 433 |
| 2013 | 373 |
| 2014 | 369 |
| 2015 | 478 |
| 2016 | 428 |
| 2017 | 405 |
| 2018 | 359 |
| 2019 | 382 |
| 2020 | 451 |
| 2021 | 267 |
| 2022 | 216 |
| 2023 | 224 |
| 2024 | 165 |
| 2025 | 186 |
| 2026 | 99 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,047,177 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| sepsisSignal | 481 | 13.0 | 12.0 | 5,342 |
| febrile neutropeniaSignal | 263 | 12.0 | 10.6 | 2,635 |
| respiratory failureSignal | 265 | 11.0 | 9.8 | 2,394 |
| renal failureSignal | 342 | 7.8 | 7.0 | 2,020 |
| acute kidney injurySignal | 366 | 7.2 | 6.5 | 1,964 |
| thrombocytopeniaSignal | 267 | 7.2 | 6.4 | 1,425 |
| pneumoniaSignal | 553 | 5.2 | 4.8 | 1,872 |
| pyrexiaSignal | 565 | 4.9 | 4.6 | 1,790 |
| hypotensionSignal | 319 | 4.8 | 4.3 | 963 |
| anaemiaSignal | 280 | 4.4 | 3.9 | 745 |
| rash | 276 | 1.9 | 1.7 | 121 |
| dyspnoea | 332 | 1.8 | 1.6 | 113 |
| diarrhoea | 362 | 1.7 | 1.5 | 104 |
| pain | 251 | 1.2 | 1.1 | 11 |
| nausea | 298 | 1.1 | 1.0 | 5 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.